Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors

• Prif Awduron: Estefanía Barral Mena (Awdur), Luis Miguel García Cárdaba (Awdur), Anna Canet Tarrés (Awdur), Eugenia Enríquez Merayo (Awdur), Alejandro Cruz Utrilla (Awdur), Jaime de Inocencio Arocena (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2020-03-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Introduction: Methotrexate (MTX) is the drug of choice for juvenile idiopathic arthritis. Its clinical efficacy is limited due to the development of adverse effects (AEs). Patients and methods: A retrospective observational study was conducted on the AEs associated with MTX therapy in children diagn...